JPS5640606A - Preparation of stable drug - Google Patents
Preparation of stable drugInfo
- Publication number
- JPS5640606A JPS5640606A JP11660779A JP11660779A JPS5640606A JP S5640606 A JPS5640606 A JP S5640606A JP 11660779 A JP11660779 A JP 11660779A JP 11660779 A JP11660779 A JP 11660779A JP S5640606 A JPS5640606 A JP S5640606A
- Authority
- JP
- Japan
- Prior art keywords
- polyoxyethylene
- pharmaceutical preparation
- carcinostatic
- acylcytosinearabinoside
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Abstract
PURPOSE: To obtain a drug suitable for a long time storage in case of pharmaceutical preparation of powder, by adding a nonionic surface active agent having a polyoxyethylene side chain to N4-acylcytosinearabinoside useful as a carcinostatic, followed by pharmaceutical preparation.
CONSTITUTION: Optionally in the presence of a vehicle (e.g., mannitol, dried crystallite cellulose, dried anhydrous silicic acid, etc.), N4-acylcytosinearabinoside useful as a carcinostatic having a low toxicity and prolonged effect is blended with a nonionic surface active agent having a polyoxyethylene side chain (e.g., polyoxyethylene fatty acid ester, polyoxyethylene hardened castor oil, polyoxyethylene castor oil, etc.) in an amount preferably 1/20W5 times that of the carcinostatic, and subjected to pharmaceutical preparation. By this metod, decomposition will never occur in case of pharmaceutical preparation of powder and the above-mentioned drug which can be preserved stably for a long time is obtained.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11660779A JPS5640606A (en) | 1979-09-11 | 1979-09-11 | Preparation of stable drug |
DE3033814A DE3033814C2 (en) | 1979-09-11 | 1980-09-09 | Drug preparation of N → 4-acylcytosine arabinosides |
IT49635/80A IT1145416B (en) | 1979-09-11 | 1980-09-09 | PHARMACEUTICAL COMPOSITION CONTAINING AN N4-ACYL-CITOSIN-ARABINOSIDE |
NO802688A NO155088C (en) | 1979-09-11 | 1980-09-10 | PROCEDURE FOR AA IMPROVE STORAGE STABILITY OF AN N4 ACYLCYTOSINARABINOSIDE. |
DK384580A DK161491C (en) | 1979-09-11 | 1980-09-10 | PROCEDURE FOR THE PREPARATION OF AN N4-ACYLCYTOSINE ARABINOSIDE PREPARATION WITH IMPROVED CHEMICAL STABILITY AND STORAGE TIME |
NLAANVRAGE8005102,A NL187727C (en) | 1979-09-11 | 1980-09-10 | MEDICINAL PRODUCT CONTAINING A NŸ4-ACYLCYTOSIN ARABINOSIDE AND SUITABLE FOR ORAL ADMINISTRATION. |
BE2/58740A BE885161A (en) | 1979-09-11 | 1980-09-10 | AN N4-ACYLCYTOSINE ARABINOSIDE AS AN ACTIVE COMPONENT-CONTAINING MEDICINAL PRODUCT |
LU82760A LU82760A1 (en) | 1979-09-11 | 1980-09-10 | DRUG COMPOSITIONS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11660779A JPS5640606A (en) | 1979-09-11 | 1979-09-11 | Preparation of stable drug |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5640606A true JPS5640606A (en) | 1981-04-16 |
Family
ID=14691347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11660779A Pending JPS5640606A (en) | 1979-09-11 | 1979-09-11 | Preparation of stable drug |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS5640606A (en) |
BE (1) | BE885161A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5939829A (en) * | 1982-08-31 | 1984-03-05 | Asahi Chem Ind Co Ltd | Method for stabilizing tumor necrotic factor |
JPH05194218A (en) * | 1991-11-20 | 1993-08-03 | Takeda Chem Ind Ltd | Oral medicine composition and its production |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5290615A (en) * | 1976-01-19 | 1977-07-30 | Asahi Chem Ind Co Ltd | Water-soluble solid and aqueous solution of n4-acylcytosine arabinosid e |
-
1979
- 1979-09-11 JP JP11660779A patent/JPS5640606A/en active Pending
-
1980
- 1980-09-10 BE BE2/58740A patent/BE885161A/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5290615A (en) * | 1976-01-19 | 1977-07-30 | Asahi Chem Ind Co Ltd | Water-soluble solid and aqueous solution of n4-acylcytosine arabinosid e |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5939829A (en) * | 1982-08-31 | 1984-03-05 | Asahi Chem Ind Co Ltd | Method for stabilizing tumor necrotic factor |
JPH0375531B2 (en) * | 1982-08-31 | 1991-12-02 | Asahi Kasei Kogyo Kk | |
JPH05194218A (en) * | 1991-11-20 | 1993-08-03 | Takeda Chem Ind Ltd | Oral medicine composition and its production |
Also Published As
Publication number | Publication date |
---|---|
BE885161A (en) | 1981-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2062465B (en) | Topical preparation containing nitroglycerine and optionally other medicaments | |
JPS5618914A (en) | Ubidecarenone composition having good absorbability | |
JPS55153715A (en) | Prolonged granule of theophylline | |
GR3017411T3 (en) | Production process of microspheres. | |
JPS5592312A (en) | Suppository containing bronchodilating compound | |
IL86395A (en) | Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil | |
JPS5640606A (en) | Preparation of stable drug | |
NO962129D0 (en) | New pharmaceutical composition for the preparation of a stable powder containing an active principle comprising a compound of acetylsalicylic acid and metoclopramide | |
JPS56138105A (en) | Acaricide | |
JPS52125630A (en) | Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine | |
JPS5218832A (en) | Method of making cosmetic preparation | |
JPS5726587A (en) | Stabilization of ascorbic acid oxidase | |
JPS6471439A (en) | Freshness retaining agent for fishes and shellfishes | |
JPS53148518A (en) | Stabilized prostaglandin e composition and its preparation | |
JPS55139313A (en) | Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it | |
JPS5294414A (en) | Production of stable solid composition or complex containing salicylic acid choline * solid dosage form containing same as effective component and use of same | |
JPS5612309A (en) | Oral drug containing ubidecarenone | |
JPS56145223A (en) | Drug composition | |
JPS5426333A (en) | Preparation of pesticide or disinfectant | |
JPS5686114A (en) | Pharmaceutical composition for suppository | |
JPS5626181A (en) | Prevention of oxidation of food | |
JPS53148528A (en) | Food preservative and preservation of food using the same | |
JPS5640607A (en) | Drug composition | |
JPS5665819A (en) | Composition for mefenamic acid pharmaceutical | |
JPS55164621A (en) | Stable solubilized liquid of vitamin k |